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We report a case of invasive pulmonary aspergillosis (IPA) following respiratory syncytial virus 
infection in an allogeneic hematopoietic stem cell transplant (HSCT) recipient with chronic
versus-host disease. Delayed diagnosis of IPA resulted in the development of a pneumothorax, a 
rare consequence of fungal pneumonia. Respiratory virus infections are often harbingers of other 
infective  organisms  in  HSCT  recipients.  More  aggressive  d
computed tomography scans of the thorax and bronchoscopy with bronchoalveolar lavage should 
be considered early in any HSCT patient presenting with respiratory virus pneumonia, particularly 
if atypical features are present or recovery is delayed.
Introduction: Pulmonary  complications  develop  in 
40% to 60% of hematopoietic cell transplant (HSCT) 
recipients  and  are  recognized  as  major  causes
morbidity and mortality.
1 The complications are more 
frequent in allogeneic recipients, especially those with 
graft  versus  host  disease  (GVHD).  Pulmonary 
infiltrates in  such patients pose major challenges for 
clinicians because of the wide differential
both infectious and noninfectious conditions. 
Community-acquired respiratory viruses (CRVs) such 
as respiratory syncytial virus (RSV), parainfluenza, and 
influenza  viruses  are  important  causes  of  acute 
infectious pulmonary complications, occ
to  30%  of  HSCT  recipients  each  year.  One
one-half  of  these  is  due  to  RSV.  The  increased 
; Open Journal System 
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We report a case of invasive pulmonary aspergillosis (IPA) following respiratory syncytial virus 
infection in an allogeneic hematopoietic stem cell transplant (HSCT) recipient with chronic
host disease. Delayed diagnosis of IPA resulted in the development of a pneumothorax, a 
rare consequence of fungal pneumonia. Respiratory virus infections are often harbingers of other 
infective  organisms  in  HSCT  recipients.  More  aggressive  diagnostic  investigations  such  as 
computed tomography scans of the thorax and bronchoscopy with bronchoalveolar lavage should 
be considered early in any HSCT patient presenting with respiratory virus pneumonia, particularly 
or recovery is delayed.
Pulmonary  complications  develop  in 
40% to 60% of hematopoietic cell transplant (HSCT) 
recipients  and  are  recognized  as  major  causes of 
The complications are more 
frequent in allogeneic recipients, especially those with 
graft  versus  host  disease  (GVHD).  Pulmonary 
infiltrates in  such patients pose major challenges for 
clinicians because of the wide differential diagnoses of 
both infectious and noninfectious conditions. 
acquired respiratory viruses (CRVs) such 
as respiratory syncytial virus (RSV), parainfluenza, and 
influenza  viruses  are  important  causes  of  acute 
infectious pulmonary complications, occurring in 15% 
to  30%  of  HSCT  recipients  each  year.  One-third  to 
half  of  these  is  due  to  RSV.  The  increased 
mortality  seen  in  RSV  infections  in  this  patient 
population  is  attributed  to  both  its  propensity  for 
causing life-threatening infections in HSCT 
as well as to a long-term decline in respiratory function 
in survivors of acute infection.
by  RSV  has  also  been  implicated  in  predisposing 
patients  to  infections  by  fungal  pathogens  such  as 
Aspergillus spp.
2 We present a case of an allogeneic 
HSCT recipient with GVHD who developed cavitary 
invasive  pulmonary  aspergillosis  (IPA)  following 
RSV-associated pulmonary injury and acute respiratory 
failure late after engraftment.
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We report a case of invasive pulmonary aspergillosis (IPA) following respiratory syncytial virus 
infection in an allogeneic hematopoietic stem cell transplant (HSCT) recipient with chronic graft-
host disease. Delayed diagnosis of IPA resulted in the development of a pneumothorax, a 
rare consequence of fungal pneumonia. Respiratory virus infections are often harbingers of other 
iagnostic  investigations  such  as 
computed tomography scans of the thorax and bronchoscopy with bronchoalveolar lavage should 
be considered early in any HSCT patient presenting with respiratory virus pneumonia, particularly 
mortality  seen  in  RSV  infections  in  this  patient 
population  is  attributed  to  both  its  propensity  for 
threatening infections in HSCT recipients 
term decline in respiratory function 
in survivors of acute infection.
2 In addition, infection 
by  RSV  has  also  been  implicated  in  predisposing 
patients  to  infections  by  fungal  pathogens  such  as 
We present a case of an allogeneic 
HSCT recipient with GVHD who developed cavitary 
invasive  pulmonary  aspergillosis  (IPA)  following 
associated pulmonary injury and acute respiratory 
failure late after engraftment.Mediterr J Hematol Infect Dis 2011; 3: Open Journal System
Figure 1. Chest X-ray with black arrows showing patchy air
A  40-year-old  male  of  Chinese  ethnicity  received 
allogeneic filgastrim-mobilised peripheral blood HSCT 
from  his  HLA  6/6  matched  sister  using 
intensity  conditioning  regimen.  He  was  in  his  first 
complete  remission  from  underlying  B
prolymphocytic  leukemia  that  had  been  diagnosed  6 
months  earlier.  The  course  of  transplantation  was 
complicated  by  steroid-refractory  grade  III  acute 
GVHD  of  the  liver  that  began  7  months  post
transplantation, requiring intensive immunosuppressive 
therapy  with  prednisolone  followed  by  subsequent 
addition of other immunosuppressive agents including 
tacrolimus,  mycophenolate  mofetil  and  sirolimus  for 
steroid-sparing  purposes.  He  continued  to  receive 
dapsone and acyclovir prophylaxis, but was not on any 
antifungal prophylaxis.
In  December  2007,  at  9  months  post
transplantation,  he  presented  with  acute
cough and shortness of breath following close contact 
with  a  client  who  had  an  upper  respiratory  tract 
infection  (URTI).  The  initial  chest  X
unremarkable  with  no  evidence  of  pneumonia.  His 
symptoms  worsened  over  the  ensuing  few  days, 
culminating one week later in acute respiratory failure 
requiring hospitalization and non-invasive mechanical 
ventilation in the intensive care unit (ICU). The patient 
was afebrile, with bilateral respiratory rhonchi on chest 
: Open Journal System
ray with black arrows showing patchy air-space changes in both lower zones and the right upper zone.
old  male  of  Chinese  ethnicity  received 
mobilised peripheral blood HSCT 
from  his  HLA  6/6  matched  sister  using  a  reduced-
intensity  conditioning  regimen.  He  was  in  his  first 
complete  remission  from  underlying  B-cell 
tic  leukemia  that  had  been  diagnosed  6 
months  earlier.  The  course  of  transplantation  was 
refractory  grade  III  acute 
GVHD  of  the  liver  that  began  7  months  post-
transplantation, requiring intensive immunosuppressive 
solone  followed  by  subsequent 
addition of other immunosuppressive agents including 
olate  mofetil  and  sirolimus  for 
sparing  purposes.  He  continued  to  receive 
dapsone and acyclovir prophylaxis, but was not on any 
In  December  2007,  at  9  months  post-
transplantation,  he  presented  with  acute-onset  dry 
cough and shortness of breath following close contact 
with  a  client  who  had  an  upper  respiratory  tract 
infection  (URTI).  The  initial  chest  X-ray  was 
ith  no  evidence  of  pneumonia.  His 
symptoms  worsened  over  the  ensuing  few  days, 
culminating one week later in acute respiratory failure 
invasive mechanical 
ventilation in the intensive care unit (ICU). The patient 
ile, with bilateral respiratory rhonchi on chest 
auscultation. Laboratory studies showed normal blood 
counts, renal and liver function. A chest x
1) showed patchy bilateral lower zone and right upper 
zone air-space changes. 
High resolution computed tomography (HRCT) of 
the  thorax  (Figure  2)  showed  bilateral  extensive, 
circumscribed  areas  of  ground
throughout  both  lung  fields  associated  with  a  fine 
reticular  pattern  in  keeping  with  pneumonitis.  There 
were no nodules or pleural-
concomitant  invasive  fungal  infection.  Empirical 
antimicrobial  therapy  with  intravenous  levofloxacin 
and trimethoprim/sulfamethoxazole was prescribed for 
community-acquired bacterial pneumonia and possible 
Pneumocystis  jiroveci pneumonitis.  Oseltamivir 
(Tamiflu)  was  added  as  the  possibility  of  influenza
associated pneumonia was entertained. 
All  microscopy  and  cultures  of  clinical  samples 
were negative for aerobic bacteria, acid
fungi.  Reverse-transcriptase  polymerase  chain 
reactions  (PCR)  performed  on  nasopharyngeal 
specimens  were  positive  for  RSV,  although  viral 
culture from the same swab was negative. Serial serum 
galactomannan  screening  and  quantitative  real
PCR for cytomegalovirus DNA from peripheral blood
were all negative. Diagnostic bronchoalveolar lavage 
(BAL) was not performed at this point owing to the
space changes in both lower zones and the right upper zone.
auscultation. Laboratory studies showed normal blood 
counts, renal and liver function. A chest x-ray (Figure 
) showed patchy bilateral lower zone and right upper 
puted tomography (HRCT) of 
)  showed  bilateral  extensive, 
circumscribed  areas  of  ground-glass  opacification 
throughout  both  lung  fields  associated  with  a  fine 
reticular  pattern  in  keeping  with  pneumonitis.  There 
-based lesions to suggest a 
concomitant  invasive  fungal  infection.  Empirical 
antimicrobial  therapy  with  intravenous  levofloxacin 
and trimethoprim/sulfamethoxazole was prescribed for 
cterial pneumonia and possible 
pneumonitis.  Oseltamivir 
(Tamiflu)  was  added  as  the  possibility  of  influenza-
associated pneumonia was entertained. 
All  microscopy  and  cultures  of  clinical  samples 
were negative for aerobic bacteria, acid-fast bacilli or
transcriptase  polymerase  chain 
reactions  (PCR)  performed  on  nasopharyngeal 
specimens  were  positive  for  RSV,  although  viral 
culture from the same swab was negative. Serial serum 
galactomannan  screening  and  quantitative  real-time 
egalovirus DNA from peripheral blood
were all negative. Diagnostic bronchoalveolar lavage 
(BAL) was not performed at this point owing to theMediterr J Hematol Infect Dis 2011; 3: Open Journal System
Figure 2. Non-contrast high resolution computed tomography axial image of the thorax with white arrows showing bi
areas of ground-glass opacification in both lungs with associated reticular changes. 
concern of worsening hypoxemia. 
The patient’s overall condition improved gradually 
over one week, with reduced oxygen requ
dyspnea. However, a repeat HRCT thorax (
weeks later showed new cavitary lesions. Nonetheless, 
a  conservative  approach  of  close  clinical  monitoring 
and  radiological  follow-up  was adopted as the  serial 
serum galactomannan tests remained negative and the 
patient’s  overall  clinical  condition  continued  to 
improve. He was discharged one week following the 
second HRCT.
However,  he  was  re-admitted  10  days  later  with 
acute  onset  right  pleuritic  chest  pain,  dyspnea
diaphoresis. Chest x-ray (Figure 4A) and CT thorax 
(Figure  4B)  showed  enlarged  thick-
lesions  in  both  lungs,  with  a  moderate
pneumothorax. Following chest tube insertion, he was 
transferred  to  the  ICU  for  invasive  mechanical
ventilation. Thoracotomy with right upper lobectomy 
was  subsequently  performed.  The  histology  was 
consistent  with IPA,  while  lung  tissue  cultures grew 
Aspergillus  fumigatus.  He  was  prescribed 
voriconazole,  which  was  continued  for  6  months. 
Serial CT thorax showed gradual regression of the left 
pulmonary cavitary lesion and complete resolution of 
the  ground  grass  changes.  His  respiratory  symptoms 
improved  despite  receiving  continued 
: Open Journal System
contrast high resolution computed tomography axial image of the thorax with white arrows showing bi
glass opacification in both lungs with associated reticular changes. 
The patient’s overall condition improved gradually 
over one week, with reduced oxygen requirement and 
dyspnea. However, a repeat HRCT thorax (Figure 3) 4 
weeks later showed new cavitary lesions. Nonetheless, 
a  conservative  approach  of  close  clinical  monitoring 
up  was adopted as the  serial 
ed negative and the 
patient’s  overall  clinical  condition  continued  to 
improve. He was discharged one week following the 
admitted  10  days  later  with 
acute  onset  right  pleuritic  chest  pain,  dyspnea and 
) and CT thorax 
-walled  cavitary 
lesions  in  both  lungs,  with  a  moderate-sized  right 
pneumothorax. Following chest tube insertion, he was 
transferred  to  the  ICU  for  invasive  mechanical
ventilation. Thoracotomy with right upper lobectomy 
was  subsequently  performed.  The  histology  was 
consistent  with IPA,  while  lung  tissue  cultures grew 
.  He  was  prescribed 
voriconazole,  which  was  continued  for  6  months. 
x showed gradual regression of the left 
pulmonary cavitary lesion and complete resolution of 
the  ground  grass  changes.  His  respiratory  symptoms 
improved  despite  receiving  continued 
immunosuppressive therapy for his ongoing extensive 
chronic GVHD. 
Discussion: IPA and respiratory syncytial virus (RSV) 
pneumonia  are  important  causes  of  morbidity  and 
mortality in allogeneic HCT recipients. The presence 
of  GVHD  and  immunosuppression  are  the  main 
predisposing risk factors for the development of both 
conditions.
1-3
RSV infection in HSCT patients generally presents 
with  the  signs  and  symptoms  of  a  URTI.  This  may 
progress to bronchiolitis, pneumonitis, and pneumonia. 
The frequency of progression of URTI to pneumonia 
was  highest  in  patients  who  were  <1  month  post
transplant  or  pre-engraftment.
pneumonia is uncommon, but previous reports, as also 
illustrated  by  our  case,  suggest  that  chronic  GVHD 
may be a potential risk factor.
The clinical pulmonary syndromes associated with
IPA  in  allogeneic  HSCT  re
similar  and  usually  rapidly  progressive,  with  initial
symptoms being that of fever, chest pain, cough, and/or 
hemoptysis.  Respiratory  failure  can  develop  with 
progressive growth of mould and inflammation, which 
can result in necrotic debris and pulmonary infarction.
Spontaneous  pneumothorax  resulting  from  IPA  is 
rare.
4,5
contrast high resolution computed tomography axial image of the thorax with white arrows showing bilateral, circumscribed 
immunosuppressive therapy for his ongoing extensive 
IPA and respiratory syncytial virus (RSV) 
pneumonia  are  important  causes  of  morbidity  and 
mortality in allogeneic HCT recipients. The presence 
of  GVHD  and  immunosuppression  are  the  main 
predisposing risk factors for the development of both 
RSV infection in HSCT patients generally presents 
with  the  signs  and  symptoms  of  a  URTI.  This  may 
progress to bronchiolitis, pneumonitis, and pneumonia. 
The frequency of progression of URTI to pneumonia 
was  highest  in  patients  who  were  <1  month  post-
engraftment.
2 Late  onset  RSV 
pneumonia is uncommon, but previous reports, as also 
illustrated  by  our  case,  suggest  that  chronic  GVHD 
may be a potential risk factor.
2
The clinical pulmonary syndromes associated with
IPA  in  allogeneic  HSCT  recipients  are  generally 
similar  and  usually  rapidly  progressive,  with  initial
symptoms being that of fever, chest pain, cough, and/or 
hemoptysis.  Respiratory  failure  can  develop  with 
progressive growth of mould and inflammation, which 
debris and pulmonary infarction.
3
Spontaneous  pneumothorax  resulting  from  IPA  is Mediterr J Hematol Infect Dis 2011; 3: Open Journal System
Figure 3. Non-contrast high resolution computed tomography axial image of the thorax showing an irregular thick
cavitary  lesion  (arrow)  with  adjacent  multiseptated  cavitary  lesion  (arrowhead).  Faint  bilateral  circumscribed  areas  of  groun
opacification are seen in both lungs with associated reticulated chages (curved arrows).
The  diagnosis  of  IPA  is  often  made  late  in  the 
course  of  disease  due  to  the  lack  of  sensitive  and 
reliable  diagnostic  techniques.  The  clinical 
manifestations  are  often  non-specific.  While 
radiological  findings  can  be  suggestive,  none  are 
pathognomonic,  and  cultures  of  respiratory  samples 
lack sensitivity.
1,3 Recently, attention has been focused 
on  improving  diagnostic  methods  for  I
Figure  4. Chest  X-ray  (A)  and  contrast-enhanced  computed  tomography  (CT)  axial  image  of  the  thorax  (
pneumothorax with bilateral thick-walled cavities. The subcutaneous emphysema seen on CT is due to the presence of a right
drain (not shown).
: Open Journal System
high resolution computed tomography axial image of the thorax showing an irregular thick
cavitary  lesion  (arrow)  with  adjacent  multiseptated  cavitary  lesion  (arrowhead).  Faint  bilateral  circumscribed  areas  of  groun
tion are seen in both lungs with associated reticulated chages (curved arrows).
The  diagnosis  of  IPA  is  often  made  late  in  the 
course  of  disease  due  to  the  lack  of  sensitive  and 
.  The  clinical 
specific.  While 
radiological  findings  can  be  suggestive,  none  are 
pathognomonic,  and  cultures  of  respiratory  samples 
Recently, attention has been focused 
on  improving  diagnostic  methods  for  IPA, including 
the use of the galactomannan enzyme immunoassay on 
BAL  fluid,  which  appears  to  be  more  sensitive  and 
specific  than  serum  galactomannan  assay.
patient’s  diagnosis  of  IPA  was  made  only  after 
resection  of  the  affected  lung.  It  remains  unknow
whether an earlier diagnostic BAL performed during 
the  acute  RSV  event  could  have  led  to  an  earlier 
diagnosis of IPA. The enthusiasm in performing BAL 
enhanced  computed  tomography  (CT)  axial  image  of  the  thorax  (
walled cavities. The subcutaneous emphysema seen on CT is due to the presence of a right
high resolution computed tomography axial image of the thorax showing an irregular thick-walled right upper lobe 
cavitary  lesion  (arrow)  with  adjacent  multiseptated  cavitary  lesion  (arrowhead).  Faint  bilateral  circumscribed  areas  of  ground  glass 
the use of the galactomannan enzyme immunoassay on 
BAL  fluid,  which  appears  to  be  more  sensitive  and 
specific  than  serum  galactomannan  assay.
6Our 
patient’s  diagnosis  of  IPA  was  made  only  after 
resection  of  the  affected  lung.  It  remains  unknown 
whether an earlier diagnostic BAL performed during 
the  acute  RSV  event  could  have  led  to  an  earlier 
enthusiasm in performing BAL 
enhanced  computed  tomography  (CT)  axial  image  of  the  thorax  (B)  showing  right-sided 
walled cavities. The subcutaneous emphysema seen on CT is due to the presence of a right-sided chest Mediterr J Hematol Infect Dis 2011; 3: Open Journal System
in patients with acute respiratory failure, as in this case, 
has  been  tempered  by  life-threatening  complications 
associated  with  the  procedure,  such  as  worsening  of 
hypoxemia and respiratory failure.
7
Our  case  lends  weight  to  previously  published 
reports suggesting that respiratory virus infections may 
play a role in the pathogenesis of bacterial or fungal 
pneumonia in  HSCT recipients.
3,8,9 In a retrospective 
analysis of a cohort of such patients, Nichols and co-
workers demonstrated the presence of co-pathogens in 
53% of 55 cases of parainfluenza-3 lower respiratory 
tract  infections.
8 Aspergillus  fumigatus was  the  most 
common  co-pathogen,  accounting  for  13  of  the  29 
patients with dual infections, and was associated with 
higher mortality rate. In another report from the same 
center, Marr and co-workers showed that patients with 
respiratory  virus  infections  after  day  40  post-HSCT 
also had a 2.1-fold increased risk of subsequent IPA.
9
Mechanisms  that  can  explain  the  association 
between  respiratory  virus  and  fungal infections  have 
not  been  elucidated.  Potential  contributing  factors 
include  GVHD  and  the  immunosuppressive  agents 
used  to  treat  this  condition  such  as  steroids  and 
calcineurin inhibitors. It is possible that RSV may itself 
predispose patients to such infections by damaging the 
respiratory epithelium and allowing other organisms to 
colonize  and  invade.  Other  potential  mechanisms 
include  the  immune-modulating  effects  of  the  virus 
itself: RSV can impair multiple antimicrobial effector 
mechanisms,  including  inhibition  of  effector  T-cell 
function as well as immunologic memory development 
in  the  respiratory  tract,  and  also  diminished 
microbicidal activity of alveolar macrophages.
2
In conclusion,  our  case  provides further  evidence 
regarding  the  direct  association  between  RSV 
infections  and  aspergillosis  in  HCT  recipients.  As 
respiratory  virus  infections  are  often  harbingers  of 
other infective organisms, more aggressive diagnostic 
investigation such bronchoscopy with BAL should be 
considered early in any HCT patients presenting with 
respiratory virus pneumonia. Further studies regarding 
the  interaction  of  RSV  with  other  post-transplant 
infections are needed.
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